Revealense
Developing a groundbreaking neurological-AI engine understand human mental state & condition
Company Overview
Snapshot
Founded in November 2021 by Dov Donin, Revealense operates with 1–10 employees. The company has secured $4.14 million across one funding round. In August 2025, Revealense partnered with Sheba ARC to launch AI-powered home neurology diagnostics.
Business overview
Revealense is developing a neurological-AI engine designed to understand human mental states and conditions by unifying biology, psychology, culture, and context into a single behavioral intelligence framework. The company's patented methodology correlates content, culture, background, and contextual events to reveal what a person expresses, conceals, feels, and how their neurology responds in real-time. Initially focusing on defense and healthcare domains, Revealense's technology aims to provide context-aware, non-invasive, human-centric assessment tools. The company leverages an extensive research base of over 14,000 contextualized video sessions and 25 million annotated behavioral frames, utilizing multimodal video analysis, behavioral science, and clinically validated AI.
Strategic signal
In August 2025, Revealense announced a significant partnership with Sheba ARC to launch AI-powered home neurology diagnostics. This collaboration signals a major advancement in the application of AI for early and accurate neurological diagnosis, particularly for conditions like autism and ADHD, and indicates strong market validation for Revealense's technology within the healthcare sector.
Company Intelligence Q&A
- What is Revealense's primary focus?
- Revealense focuses on developing a neurological-AI engine to understand human mental states and conditions, integrating biology, psychology, culture, and context into a behavioral intelligence framework.
- When was Revealense founded and by whom?
- Revealense was founded in November 2021 by Dov Donin.
- What was a key strategic development for Revealense in August 2025?
- In August 2025, Revealense partnered with Sheba ARC to launch AI-powered home neurology diagnostics, aiming to provide rapid and accurate identification of conditions like autism and ADHD.
- What is the total capital raised by Revealense?
- Revealense has raised $4.14 million across one funding round.
- Which sectors does Revealense primarily serve?
- Revealense primarily serves the defense and healthcare sectors, providing tools for human assessment and neurological diagnosis.